TAVR and stroke: A common evolution

Periprocedural cerebrovascular events (CVE) after transcatheter aortic‐valve replacement (TAVR) are infrequent (but not rare) and fearsome complications. Stroke rates after TAVR remain below 4% in recent literature, but data on predictors of peri‐procedural CVE occurrence is generally controversial...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarantini, Giuseppe, Cardaioli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Valvular and Structural Heart Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544584/
https://www.ncbi.nlm.nih.gov/pubmed/35485733
http://dx.doi.org/10.1002/ccd.30220
_version_ 1784804628648427520
author Tarantini, Giuseppe
Cardaioli, Francesco
author_facet Tarantini, Giuseppe
Cardaioli, Francesco
author_sort Tarantini, Giuseppe
collection PubMed
description Periprocedural cerebrovascular events (CVE) after transcatheter aortic‐valve replacement (TAVR) are infrequent (but not rare) and fearsome complications. Stroke rates after TAVR remain below 4% in recent literature, but data on predictors of peri‐procedural CVE occurrence is generally controversial and inconsistent. The incidence of peri‐procedural stroke seems to be lower in patients treated with TAVR rather than surgical aortic valve replacement, especially among those patients with low‐surgical risk.
format Online
Article
Text
id pubmed-9544584
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95445842022-10-14 TAVR and stroke: A common evolution Tarantini, Giuseppe Cardaioli, Francesco Catheter Cardiovasc Interv Valvular and Structural Heart Diseases Periprocedural cerebrovascular events (CVE) after transcatheter aortic‐valve replacement (TAVR) are infrequent (but not rare) and fearsome complications. Stroke rates after TAVR remain below 4% in recent literature, but data on predictors of peri‐procedural CVE occurrence is generally controversial and inconsistent. The incidence of peri‐procedural stroke seems to be lower in patients treated with TAVR rather than surgical aortic valve replacement, especially among those patients with low‐surgical risk. John Wiley and Sons Inc. 2022-04-29 2022-05-01 /pmc/articles/PMC9544584/ /pubmed/35485733 http://dx.doi.org/10.1002/ccd.30220 Text en © 2022 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Valvular and Structural Heart Diseases
Tarantini, Giuseppe
Cardaioli, Francesco
TAVR and stroke: A common evolution
title TAVR and stroke: A common evolution
title_full TAVR and stroke: A common evolution
title_fullStr TAVR and stroke: A common evolution
title_full_unstemmed TAVR and stroke: A common evolution
title_short TAVR and stroke: A common evolution
title_sort tavr and stroke: a common evolution
topic Valvular and Structural Heart Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544584/
https://www.ncbi.nlm.nih.gov/pubmed/35485733
http://dx.doi.org/10.1002/ccd.30220
work_keys_str_mv AT tarantinigiuseppe tavrandstrokeacommonevolution
AT cardaiolifrancesco tavrandstrokeacommonevolution

Ejemplares similares